The disruption of GABAergic system in seizures associated with cortical malformation is also supported by the particular efficacy of the GABA transaminase inhibitor VGB against epileptic spasms in tuberous sclerosis complex (35), which shares certain pathophysiological traits with MCDs (38). The gene discussed is ABAT; the disease is tuberous sclerosis.